Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Humacyte Inc (NQ: HUMA )

5.010 +0.070 (+1.42%)
Streaming Delayed Price Updated: 10:18 AM EDT, May 26, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 37,906
Open 4.930
Bid (Size) 5.000 (3)
Ask (Size) 5.020 (1)
Prev. Close 4.940
Today's Range 4.890 - 5.070
52wk Range 4.265 - 17.45
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
73 Biggest Movers From Yesterday
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday. 
Via Benzinga
41 Stocks Moving In Monday's Mid-Day Session
Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results. 
Via Benzinga

Performance

YTD
-32.30%
-32.30%
1 Month
-34.42%
-34.42%
3 Month
-0.20%
-0.20%
6 Month
-52.38%
-52.38%
1 Year
-58.93%
-58.93%

More News

Read More
Earnings Scheduled For May 13, 2022
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Humacyte's Return On Capital Employed Insights
Via Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
Via Benzinga
Humacyte Posts Preclinical Data Of Small-Diameter Human Acellular Vessel In Bypass Grafting
Via Benzinga
Earnings Scheduled For March 29, 2022
Via Benzinga
How To Attend Humacyte Q4 2021 Earnings Conference Call
Via Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Via Benzinga
Humacyte's Human Acellular Vessel Shows Long Term Benefit In Hemodialysis Patients
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2021
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks Hitting New 52-Week Lows Today
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2021
Via Benzinga
64 Biggest Movers From Yesterday
Via Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021
Via Benzinga
After NASDAQ Debut, Humacyte's Investor Adds $25M Infusion
Via Benzinga
3 Stocks Insiders Are Buying
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021
Via Benzinga
72 Biggest Movers From Yesterday
Via Benzinga
53 Biggest Movers From Friday
Via Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
Via Benzinga
Exposures COVID-19 Product Safety
54 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.